Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > 17 straight days of closing between 67 and 70

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Jun 01, 2022 2:05pm

82 Views

Post# 34724004

RE:RE:17 straight days of closing between 67 and 70

Don't you remember? He flips it and ALWAYS makes money 5x5 = 25% lmao!!

davgro wrote:

Duster340 wrote: 4 days @70
6 days @69
5 days@68
2 days @67
but you know what they say the longer the base the bigger the breakout

Thank you for taking the "deep dive" into ATE's closing share price. Your technical analysis is very thorough and definitely adds enormous insight into ATE's stock price trends.

I guess a 3 cent variance in share price on very low trading volumes doesn't sit well with a "penny flipping" day trading troll ? No need to answer, its a rhetorical question.

Keep up the great posts Dumpster !!